CN103041378A - Bedsore nursing liquid - Google Patents
Bedsore nursing liquid Download PDFInfo
- Publication number
- CN103041378A CN103041378A CN2012105180092A CN201210518009A CN103041378A CN 103041378 A CN103041378 A CN 103041378A CN 2012105180092 A CN2012105180092 A CN 2012105180092A CN 201210518009 A CN201210518009 A CN 201210518009A CN 103041378 A CN103041378 A CN 103041378A
- Authority
- CN
- China
- Prior art keywords
- percent
- nursing liquid
- bedsore
- marine biological
- free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to bedsore nursing liquid, in particular to bedsore nursing liquid containing marine biological components and used for preventing and controlling bedsores. The selected formula comprises the following components in percentage by weight: 2.0 to 4.0 percent of carboxymethyl chitosan, 2.0 to 3.0 percent of algal polysaccharide, 6.0 to 8.0 percent of marine biological lysozyme, 5.0 to 7.0 percent of algae powder, and the balance of purified water. The bedsore nursing liquid has the following advantages: (1) the detection proves that the nursing liquid containing the marine biological bacteriostatic components is safe, nontoxic, irritation-free, corrosion-free and residue-free and has a remarkable sterilization effect; the average killing rate on staphylococcus aureus, escherichia coli and candida albicans in 2 minutes is more than 99.2 percent; the average killing rate in 5 minutes is 99.999 percent; bacteria on the surfaces of the bedsores can be quickly killed, and the development of diseases is effectively controlled; (2) due to multiple marine biological components, the nursing liquid has a health-care effect on skin and can promote the metabolism of body cells and quicken healing of bedsore surfaces; (3) the nursing liquid is easy and convenient to use and does not have irritation to the skin, and patients do not have pain; and (4) the production process is simple.
Description
Technical field
The present invention relates to a kind of nursing care of decubitus ulcer liquid, relate in particular to a kind of nursing care of decubitus ulcer liquid of marine natural product, be used for prevention and the control of hemorrhoid.
Background technology
Hemorrhoid are called again pressure ulcer, are because the long-term pressurized of local organization, continuous ischemia, anoxia, malnutrition occur and cause skin resistance to reduce, and tissue fester is downright bad, also easily causes the decubital ulcer complication.The tool report approximately has 70,000 people to die from the decubital ulcer complication every year, has become bed my No.1 " killer ".
The method for the treatment of decubital ulcer is most at present adopts hydrogen peroxide, ethanol, povidone iodine wiping wound surface, but has zest, and the patient has misery; Band bed sore ointment mostly is Chinese medicine ingredients, takes effect slowly.
Summary of the invention
The objective of the invention is to develop a kind of nontoxic, non-stimulated, effectively control decubital ulcer development and can accelerate the nursing care of decubitus ulcer liquid of wound healing, can alleviate the patient suffering, reduce the incidence rate of decubital ulcer complication.Main points of the present invention are to select suitable Allopelagic sterilizing component, carry out rationally compositely, form a kind of marine organisms nursing care of decubitus ulcer liquid through emulsion reaction.
The prescription following (component and percentage by weight % thereof) that the present invention selects:
Carboxymethyl chitosan 2.0-4.0;
Sargassum polysaccharides 2.0-3.0;
Marine organisms lysozyme 6.0-8.0;
Sargassum powder 5.0-7.0
Pure water to 100
The antibacterial action of carboxymethyl chitosan is remarkable, and discharges very special bio-energy, and harmonious resonance occurs human body, internal body is arrived in the energy special delivery, the illness of intelligent reparation human body various types of cells tissue and different internal organs, targeting is stronger, and health-care effect is very strong.
The effects such as that Sargassum polysaccharides has is antibiotic, antiviral, antitumor, mutation, radioprotective and enhancing immunity
The marine organisms lysozyme is Chinese patent CN200410097081 disclosed " the bacillus cereus S-12 of a kind of new type marine microorganism of lysozyme and high yield lysozyme thereof ", and this patent discloses cultural method and the purposes of this marine microorganism neuzyme in the lump.One of main degerming composition that lysozyme after the cultivation is filled a prescription for this reason is biological disinfectant, has no side effect, and is non-stimulated to skin, and has pair antibacterial to have long-acting inhibitory action.
Sargassum powderBe take the marine natural Sargassum as major ingredient, be aided with a small amount of marine microalgae retrofit and form, the natural seaweed powder is rich in the trace element such as Sargassum polysaccharides, mannitol, aminoacid, protein, vitamin and potassium, ferrum, calcium, phosphorus, iodine, selenium, cobalt.Can reduce the dermatosis sickness rate, improve skin allergy and pruritus, accelerate dermopathic healing, promote the recovery of wound, the effect of nourishes rough skin.
The preparation method of product of the present invention is:
One, the cultivation of marine organisms lyase:
According to the cultural method of Chinese patent CN200410097081 disclosed " the bacillus cereus S-12 of a kind of new type marine microorganism of lysozyme and high yield lysozyme thereof ", the liquid of cultivating the marine organisms lysozyme is for subsequent use.
Two, weighing:
According to formula proportion, with carboxymethyl chitosan, Sargassum polysaccharides, the accurate weighing of Sargassum powder.
Three, stirring and emulsifying process:
(1) pure water that will fill a prescription required adds in the emulsion tank, is heated to 40 degrees centigrade.
(2) press formula proportion carboxymethyl chitosan, Sargassum polysaccharides, Sargassum powder are added in the emulsifying filling, stir after 45 minutes stopped heating.
When (3) treating that temperature is down to 30 degrees centigrade, cultured marine organisms lysozyme is added emulsion tank according to formula proportion, stirred 15 minutes, the control temperature is no more than 30 degrees centigrade.
(4) packing after the cooling.
Four, CCP:
(1) notice that the step 3 temperature can not surpass 30 degrees centigrade, excess Temperature can cause the activity decreased of marine organisms lysozyme.
(2) industrial water is reverse-osmosis pure water.
Beneficial effect of the present invention is:
(1) detection according to embodiment prescription one proves: the present technique product contains, marine organisms degerming antipathogenic composition, safety non-toxic, non-stimulated, without the burn into noresidue, sterilization effect is remarkable, and 2min is to the average kill ratio of staphylococcus aureus, escherichia coli, Candida albicans〉99.2%;Acting on 5 min average kill ratios is 99.999%; Effect 10min average kill ratio is 100%; Working concentration is low, bactericidal effect good.Can kill fast the decubital ulcer surface bacteria, effectively control the decubital ulcer development.
(2) multiple marine natural product has health care, moistens effect, promotes the metabolism of body cell to accelerate the healing on decubital ulcer surface skin.
(3) using method is easy, with cotton swab wiping bedsore wound, or uses the cotton balls cold compress.
(4) to the skin nonirritant, patient's no pain.
(5) production technology is simple.
The specific embodimentThe present invention is described in further detail below in conjunction with embodiment:
Be configured according to following table institute column data (percentage by weight %) and described step thereof:
Prescription one:
Carboxymethyl chitosan 2.0;
Sargassum polysaccharides 2.0;
Marine organisms lysozyme 6.0;
Sargassum powder 5.0
Pure water to 100
___________________________________________________________________
Prescription two:
Carboxymethyl chitosan 3.0;
Sargassum polysaccharides 2.0;
Marine organisms lysozyme 7.0;
Sargassum powder 6.0
Pure water to 100
____________________________________________________________________
Prescription three:
Carboxymethyl chitosan 3.0;
Sargassum polysaccharides 2.0;
Marine organisms lysozyme 7.0;
Sargassum powder 7.0
Pure water to 100
The difference of above three kinds of embodiments is that the content of effective ingredient is different, can select voluntarily as required.
Claims (2)
1. a nursing care of decubitus ulcer liquid is used for prevention and the control of hemorrhoid.
2. the prescription of selecting is (component and percentage by weight % thereof): carboxymethyl chitosan 2.0-4.0; Sargassum polysaccharides 2.0-3.0; Marine organisms lysozyme 6.0-8.0; Sargassum powder 5.0-7.0; Pure water to 100.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105180092A CN103041378A (en) | 2012-12-06 | 2012-12-06 | Bedsore nursing liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105180092A CN103041378A (en) | 2012-12-06 | 2012-12-06 | Bedsore nursing liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103041378A true CN103041378A (en) | 2013-04-17 |
Family
ID=48054387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105180092A Pending CN103041378A (en) | 2012-12-06 | 2012-12-06 | Bedsore nursing liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041378A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1569071A (en) * | 2003-07-26 | 2005-01-26 | 陈平 | Medicine for diminishing the inflammation and reducing the pain, subsiding swelling to dissipate indurated mass, dredging meridian to removing stagnation |
| CN1687397A (en) * | 2004-12-21 | 2005-10-26 | 中国水产科学研究院黄海水产研究所 | New type marine microorganism of lysozyme and bacillus 5-12 of producing lysozyme in high yield |
| CN1771981A (en) * | 2005-10-18 | 2006-05-17 | 夏运岳 | Pile ointment |
| CN101618047A (en) * | 2009-08-11 | 2010-01-06 | 聊城大学 | Preparation method and application of nanocomposite of silver, chitosan and/or derivative thereof |
| CN102423249A (en) * | 2011-11-25 | 2012-04-25 | 铜陵洁雅生物科技股份有限公司 | Medical nursing wet tissue with functions of deodorizing and preventing bedsore and preparation method thereof |
-
2012
- 2012-12-06 CN CN2012105180092A patent/CN103041378A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1569071A (en) * | 2003-07-26 | 2005-01-26 | 陈平 | Medicine for diminishing the inflammation and reducing the pain, subsiding swelling to dissipate indurated mass, dredging meridian to removing stagnation |
| CN1687397A (en) * | 2004-12-21 | 2005-10-26 | 中国水产科学研究院黄海水产研究所 | New type marine microorganism of lysozyme and bacillus 5-12 of producing lysozyme in high yield |
| CN1771981A (en) * | 2005-10-18 | 2006-05-17 | 夏运岳 | Pile ointment |
| CN101618047A (en) * | 2009-08-11 | 2010-01-06 | 聊城大学 | Preparation method and application of nanocomposite of silver, chitosan and/or derivative thereof |
| CN102423249A (en) * | 2011-11-25 | 2012-04-25 | 铜陵洁雅生物科技股份有限公司 | Medical nursing wet tissue with functions of deodorizing and preventing bedsore and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 郜爱青等: "联合用药治疗褥疮的疗效观察", 《河南实用神经疾病杂志》, vol. 6, no. 3, 31 May 2003 (2003-05-31), pages 1 - 2 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988231B (en) | Feminine care solution and preparation method thereof | |
| CN102091097B (en) | Washing-free puerpera perineum medical-care gel and preparation method thereof | |
| CN102178632A (en) | Application of ozonized oil to preparation of raw materials of medical health-care products | |
| CN106309237A (en) | Hyaluronic acid private part care gel and preparation method thereof | |
| CN102943006B (en) | Essential oil soap with bacterial killing and bacterial inhibiting functions | |
| CN101361535B (en) | Compound pollen cream and preparation method thereof | |
| CN104095999A (en) | Ozonized borneol tea oil | |
| CN108042578A (en) | A kind of health care vaginal jellies containing compound probiotic ingredient | |
| CN103040638A (en) | False tooth nursing liquid containing marine biological sterilization components | |
| CN102008399B (en) | Preparation method of antimicrobial mouthwash | |
| CN101543658B (en) | Cervical cap for preventing and treating cervical erosion and preparation method thereof | |
| CN101803611B (en) | Citric acid iodine disinfectant and method for preparing same | |
| CN101797269B (en) | Physiological balance liquid for adjusting microecology in vaginas of women | |
| CN102078274B (en) | Antibacterial plant essence hand cream applicable to infants and pregnant women | |
| CN102090417B (en) | Preparation method of living disinfectant | |
| CN109223760B (en) | Application of benzofuran derivative | |
| CN103041378A (en) | Bedsore nursing liquid | |
| CN102335462A (en) | Nano iodine-chitosan cervical disease treating membrane agent and preparation method of membrane | |
| CN109091596A (en) | A kind of compound nursing gel for women and preparation method thereof | |
| CN107308104A (en) | A kind of preparation method of gynecological gel | |
| CN103040675A (en) | Bacteria-removing marine organism male cleaning liquid | |
| CN101310702B (en) | Emulsion type gel preparation containing chlorhexidine and alcohol | |
| CN102552650A (en) | Skin antibacterial agent and preparation method thereof | |
| CN103858939A (en) | Improvement fluid for ornamental fish farming water body | |
| CN102688156A (en) | Iodine-containing gynecologic disinfection and sterilization irrigant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130417 |